Concerning mandatory health-care coverage for preventive kidney function screening services.
Summary
HB26-1019 requires health insurance policies and contracts issued or renewed in Colorado to cover preventive kidney function screening services without cost-sharing. The bill adds annual kidney screening to the state’s mandated preventive health-care benefits and specifies that the screening should include tests such as glomerular filtration rate (GFR) and urine albumin-creatinine testing. Coverage would apply first to large employer plans on or after January 1, 2027, and then to individual and small group plans on or after January 1, 2028, so long as the state is not required to defray the cost of the benefit under federal law.
The bill also amends the state employee group benefit plan statute to exclude this new mandated coverage from the specifications for those plans. It includes a legislative declaration explaining that chronic kidney disease is common, often undiagnosed, and expensive to treat, and that early screening can reduce later costs and improve outcomes. The bill is structured to fit within Colorado’s existing framework for mandated preventive services and includes language addressing high-deductible health plans and federal preventive-care rules.
The overall sentiment reflected in the bill text is strongly supportive of expanded preventive care. The legislative findings emphasize the health and financial burden of chronic kidney disease, the high rate of undiagnosed disease, and the value of early detection, suggesting the bill is intended as a public health and cost-containment measure. The bill’s sponsorship and successful enactment also indicate that it advanced with sufficient support to become law.
The main point of contention built into the bill is cost and federal compliance. The bill repeatedly conditions coverage for individual and small group plans on the state not being required to pay for the benefit, reflecting concern about state defrayal obligations under federal health insurance law. Another practical issue is how the mandate interacts with high-deductible health plans and whether the screening qualifies as preventive care for tax-advantaged health savings account purposes. The exclusion of state employee plans from the new mandate may also reflect budgetary or administrative concerns.
Impact
HB26-1019 amends Colorado’s insurance code, specifically the statute governing mandatory preventive health-care coverage, to add annual kidney function screening as a required covered benefit. It also modifies the state employee group benefit plan statute so that the new kidney screening mandate does not apply to those plans. As a result, insurers in Colorado must cover specified kidney screening tests for applicable plans on the bill’s phased-in schedule, subject to the bill’s federal-law limitation on state defrayal.
Sentiment
The bill appears to have been received positively overall, with a clear public-health rationale and no recorded committee transcript or vote history in the provided materials indicating organized opposition. Its findings frame the measure as a way to improve early detection, reduce dialysis and transplant costs, and address disparities in chronic kidney disease. The fact that it was signed by the governor suggests it ultimately had enough support to become law.
Contention
The principal contention is financial: whether the state would be required to defray the cost of the new benefit under federal law, which would make the individual and small group coverage requirement inoperative. Related concerns include the effect on premiums and plan design, especially for high-deductible health plans and health savings account compatibility. The bill also creates a carve-out for state employee plans, which may reflect disagreement or caution about extending the mandate to public employee coverage.